and in Nature Cell Biology [4] , have provided insight into the mechanism by which autophagy is stimulated when cellular energy production declines. During autophagy, part of the cytoplasm containing the material to be degraded becomes surrounded by a double membrane, resulting in the formation of an autophagosome. The outer autophagosomal membrane then fuses with a lysosome, the inner autophagosomal membrane vesicle is released into the lysosomal interior and this vesicle with its sequestered macromolecular material becomes degraded. The degradation products are returned to the cytosol for reutilization in metabolism, completing the autophagic process. The formation of the autophagosome, a process in which at least 18 different Atg (autophagy-related) proteins participate, is the rate-controlling step in autophagy. Among these proteins are the protein kinases Unc-51-like kinases 1 or 2 (Ulk1 or Ulk2, respectively -the mammalian homologs of the yeast Atg1), components of a multi-protein complex that also contains Atg13, Atg101 and FIP200 and which is involved in the initiation of autophagosome formation [2] .
Autophagy is tightly controlled by the mammalian target of rapamycin (mTOR)-dependent signal transduction pathway, which responds to growth factors and changes in amino acid levels [1] (Figure 1 ). Amino acids inhibit autophagy by activating the protein kinase mTOR within the mTORC1 complex. The molecular target of mTOR in the autophagic machinery is Ulk1, which becomes inhibited by mTOR-mediated phosphorylation, although the exact phosphorylation sites had not been described [2, [5] [6] [7] . Amino acids signal to mTOR through the Rag proteins in the mTORC1 complex [8, 9] , while insulin activates mTOR through the G protein Rheb, which is also part of this complex [10] ( Figure 1 ). Inhibition of mTOR by amino-acid depletion or by treatment with the mTOR inhibitor rapamycin stimulates autophagy [1] .
Autophagy can also be activated by impairment of cellular ATP production. Decreased ATP production stimulates AMP-activated protein kinase (AMPK), which, in line with its role in switching on catabolic pathways [11] , not only stimulates but is also essential for autophagy under energy-deprived conditions [1, 12, 13] . Stimulation of AMPK inactivates mTOR [14] through AMPK-mediated phosphorylation of both TSC2 [15] and Raptor [16] and results in association of AMPK with Ulk1 [17] (Figure 1) . Now, following up on these data, the recent studies by Egan et al. [3] and Kim et al. [4] have shown that AMPK increases autophagy not only indirectly through inactivation of mTOR but also directly through phosphorylation of Ulk1.
Egan et al. [3] used a two-part screen to identify conserved substrates of AMPK. First, they searched eukaryotic databases for proteins containing a conserved AMPK substrate motif. Second, because in vivo substrates of AMPK not only conform to this motif but also bind to the phospho-binding protein 14-3-3 [16, 17] In the study by Kim et al. [4] , also carried out with mammalian cells, systematic Ulk1 deletion and mutation experiments were performed and the accumulation of LC3-II, the lipidated form of the protein LC3 (the homolog of yeast Atg8), following lysosomal inhibition, an established measure of autophagic flux, was examined. The authors used glucose depletion to stimulate AMPK and autophagy and, in combination with in vitro phosphorylation experiments, identified Ser 317 and Ser 777 as the major AMPK phosphorylation sites of Ulk1, which they found to be essential for its activity. Interestingly, in the presence of nutrient excess, activation of mTOR was found to prevent Ulk1 activation through phosphorylation of Ulk1 at Ser 757 , which disrupted the interaction of Ulk1 with AMPK. In other words, phosphorylation of Ulk1 by AMPK and mTOR has opposing effects on its activity and thus on autophagy. This coordinated phosphorylation of Ulk1 by mTORC1 and AMPK provides an exquisite mechanism for nutrient signal integration to ensure proper adjustment of autophagic flux in response to metabolic requirements [4] ( Figure 1) .
It is important to stress that, in contrast to glucose depletion, amino-acid starvation (or rapamycin administration) stimulated autophagy by an AMPK-independent mechanism, did not increase Ser 317 and Ser 377 phosphorylation of Ulk1, did not activate AMPK, and was also observed Figure 1 . Stimulation of autophagy by AMPK. mTOR is part of the mTORC1 complex, which also contains Raptor, Rheb, PRAS40 and GbL. AMPK stimulates Ulk1 and autophagy by coordinated inhibition of mTOR through phosphorylation of TSC2 and Raptor, and phosphorylation of Ulk1. mTOR, activated by amino acids and insulin, phosphorylates Ulk1 at a different site from the site phosphorylated by AMPK, prevents association of Ulk1 and AMPK, and inhibits Ulk1 activity and autophagy. Abbreviations: PKB, protein kinase B; Rag, Ras-related small GTP-binding protein; Raptor, regulatory associated protein of mTOR; Rheb, Ras homolog enriched in brain; mTOR, mammalian target of rapamycin; TSC, tuberous sclerosis complex; Ulk1, Unc-51-like kinase 1. in AMPK-deficient cells. Clearly, activation of Ulk1 by amino-acid starvation proceeds by a different mechanism than activation of Ulkl by energy depletion [4] .
Autophagy
The studies by Egan et al. [3] and by Kim et al. [4] clearly indicate that AMPK can directly phosphorylate Ulk1 and in this way provides a mechanism for the activation of autophagy when cellular energy production becomes compromised. Surprisingly, the two studies [3, 4] are not in agreement with regard to the position of the AMPK phosphorylation sites in Ulk1. One can only guess for the reasons underlying these differences. A possible explanation is that accumulation of mitochondria [3] reflects a specific form of autophagy, mitophagy, rather than non-specific bulk autophagy, as measured by LC3-II accumulation [4] , and that regulation of these two modes of autophagy requires different phosphorylation sites on Ulk1 [18] .
Phosphorylation of Ulk1 by AMPK occurs in combination with the activation of autophagy via inhibition of mTOR activity through phosphorylation of TSC2 and Raptor (Figure 1 ). The fact that AMPK acts at multiple levels to stimulate flux through the autophagic pathway resembles the mechanism by which another protein kinase, cAMP-dependent protein kinase (PKA), affects the flux through metabolic pathways, e.g. its coordinated inhibition of hepatic glycolysis through simultaneous phosphorylation of phosphofructokinase-2 and of pyruvate kinase [19] . This inhibition of glycolysis, combined with the stimulatory effect of PKA on hepatic glycogen breakdown and on autophagy to provide amino acids as gluconeogenic substrates, ensures the maximal output of glucose in response to a rise in glucagon levels during starvation in mammals. mTORmediated signaling is inhibited by glucagon [1] and this may be sufficient for the induction of autophagy. However, it is likely that, in analogy with AMPK, Ulk1 is also a substrate for PKA in mammalian cells. In yeast cells, Atg1 is, indeed, a PKA substrate, although in this case this leads to inhibition rather than stimulation of autophagy [20] . In conclusion, the data of Egan et al. [3] and of Kim et al. [4] on AMPK-mediated phosphorylation of Ulk1 provide a fascinating mechanism responsible for the initiation of autophagy when cellular ATP production falls. This work also nicely extends early studies on the involvement of AMPK in the control of autophagy [12, 13] . Imagine yourself sleeping in your dark bedroom with its lofty vaulted ceilings and spartan decor. This bedroom is clean and serene; at least, until the alarm clock jolts you awake. Keeping your eyes firmly closed, you frantically reach out to find the 'snooze' button with the hope of a few more minutes of torpor. A deconstruction of this vignette into its component neurobiological processes would
